NCT03581136View on ClinicalTrials.gov

Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod

NAActive, not recruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

April 22, 2019

Primary Completion Date

May 25, 2028

Study Completion Date

June 28, 2030

Conditions
Breast Cancer
Interventions
DEVICE

Dose Fractionation

Patients will receive 5 fractions of radiation. These should not be on consecutive days. At least 40 hours between each fraction and a maximum of 21 days to complete, i.e.: Tuesday, Thursday, Monday, Wednesday, Friday.

Trial Locations (2)

21201

University of Maryland Medical Center, Baltimore

75390

UT Southwestern Medical Centre, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT03581136 - Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod | Biotech Hunter | Biotech Hunter